|Bid||9.96 x 800|
|Ask||10.05 x 900|
|Day's Range||9.93 - 10.36|
|52 Week Range||9.93 - 57.64|
|Beta (5Y Monthly)||1.39|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 01, 2022 - Aug 05, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||30.67|
Subscribe to Yahoo Finance Plus to view Fair Value for TCMD
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of -35.48% and 6.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
First Quarter Revenue Increased 12% Year-Over-YearMINNEAPOLIS, May 02, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today reported financial results for the first quarter ended March 31, 2022. First Quarter 2022 Summary: Total revenue increased 12% year-over-year to $48.0 million, compared to $42.8 million in
Avation Medical, an innovative neuromodulation and digital health company pioneering a wearable system to treat the symptoms of overactive bladder (OAB) and urge urinary incontinence (UUI), today announced the appointment of Darren Wennen as its Chief Marketing Officer. He will be responsible for all aspects of marketing, sales operations and customer care as the Company prepares to bring its novel wearable therapy and digital support system to market.